Home ANA Therapeutics

ANA Therapeutics

acquired
Seed Round Financing
Novel Coronavirus Vaccine Developer
Basic
Enterprise Profile

Basic Information

ANA Therapeutics is a biotechnology company developing a novel coronavirus vaccine aimed at saving human lives. It is advancing a therapy using Niclosamide to address the coronavirus pandemic, enabling medical practitioners to treat patients with COVID-19.
ANA Therapeutics
SanFrancisco,California,United States of America
less than 15 people
January 01, 2020
--

Enterprise Profile

Industrial Sector
New Drug Development Vaccine Formulation Production
Technology
Biotechnology
Concept
Vaccination Department of Pharmacy
Application Scenarios
Traditional Vaccines (Biological Products for Prevention) Novel Coronavirus